Teva v. Sandoz: Indefinite Patent Claims
A Little history of the case: Sandoz -Appellants submitted Abbreviated New Drug Applications (ANDAs) to the Food and Drug Administration (FDA) seeking approval to market generic versions of Copaxone®. Teva, which markets this drug sued Appellants for patent infringement under 35 U.S.C. § 271(e)(2)(A). Patent involved is US 5800808 A claiming Copolymer “having a [...]





